Affimed N.V.
(NASDAQ : AFMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.35%357.451.2%$827.61m
AMGNAmgen Inc.
-0.29%189.931.2%$541.51m
CELGCelgene Corporation
0.34%85.391.2%$509.27m
GILDGilead Sciences, Inc.
0.36%77.650.9%$475.17m
VRTXVertex Pharmaceuticals Incorporated
0.19%177.731.9%$314.12m
REGNRegeneron Pharmaceuticals, Inc.
-0.30%366.022.6%$276.06m
ILMNIllumina, Inc.
0.72%313.393.5%$271.32m
BLUEBluebird Bio, Inc.
-0.44%179.5515.7%$196.65m
SRPTSarepta Therapeutics, Inc.
-0.49%132.6616.6%$195.85m
ALXNAlexion Pharmaceuticals, Inc.
-0.56%134.402.0%$177.56m
NKTRNektar Therapeutics
1.17%49.305.6%$174.04m
EXASExact Sciences Corporation
-0.21%67.4825.4%$155.37m
EXELExelixis, Inc.
0.09%21.316.4%$135.49m
BMRNBioMarin Pharmaceutical Inc.
0.40%102.314.4%$123.13m
AAgilent Technologies, Inc.
-0.05%63.821.5%$110.50m

Company Profile

Affimed NV is a clinical stage biopharmaceutical company, which engages in discovering and developing highly targeted cancer immunotherapies. The company has three proprietary platform technologies which includes: NK-cell TandAbs, T-cell TandAbs and Trispecific Abs. The company was founded in 2000 and is headquartered in Heidelberg, Germany.